ライフサイエンスコーパス: calcitonin

1 delta/notch-like EGF repeat containing; and calcitonin.

2 ure peptide as compared to undigested salmon calcitonin.

3 Alzheimer's amyloid-beta, human amylin, and calcitonin.

4 Here we show that calcitonin, a hormone product of the thyroid gland invol

5 Quantification of undigested salmon calcitonin, after solid-phase extraction from plasma, re

6 type cells passaged in media containing only calcitonin and a GSK3 inhibitor.

7 eful work-up, including measurement of serum calcitonin and carcinoembryonic antigen (and their doubl

8 al based on such prognostic factors as serum calcitonin and carcinoembryonic antigen (CEA) doubling t

9 Calcitonin and carcinoembryonic antigen (CEA) doubling t

10 come of (18)F-FDG PET or (18)F-DOPA PET with calcitonin and CEA doubling times in 47 MTC patients.

11 Calcitonin and CEA levels correlated significantly with

12 separation, detection, and quantification of calcitonin and each of its precursors in human cancer ce

13 overy and characterization of O-glycosylated calcitonin and its analogous biosynthetic precursors.

14 he sequence from Asp(15) to Phe(19) of human calcitonin and reported as the minimal amyloidogenic mod

15 different therapeutic polypeptides; insulin, calcitonin, and exenatide across the monolayer.

16 Transport of insulin, calcitonin, and exenatide measured at different loading

17 es and clinical observations (eg, oestrogen, calcitonin, and teriparatide) or opportunistic repurposi

18 The expression of Samd9L was upregulated by calcitonin, and this was preceded by a significant incre

19 or 4, heart-type fatty acid binding protein, calcitonin, and tumor necrosis factor-related apoptosis-

20 ses, and persistently elevated postoperative calcitonin; and argue for the aggressive management of e

21 ata strongly suggest antiparallel beta-sheet calcitonin assembly, whereas modeling studies on the sho

22 de represents only partially the full-length calcitonin behavior.

23 we present two crystal structures of salmon calcitonin-bound, GlcNAc-bearing CTR ECD at 1.78 and 2.8

24 complex with a truncated analogue of salmon calcitonin ([BrPhe(22)]sCT(8-32)) has been determined to

25 tion show sixfold lower levels of myocardial calcitonin compared to control individuals with normal h

26 The hormone calcitonin (CT) is primarily known for its pharmacologic

27 or (CTR) and the CTR-like receptor (CLR) for calcitonin (CT), amylin (Amy), calcitonin gene-related p

28 LDTg amylin receptors by the agonist salmon calcitonin dose-dependently reduces body weight, food in

29 lidate results from molecular simulations of calcitonin family peptides in aqueous solution.

30 amino-acid peptide hormone belonging to the calcitonin family, is an intrinsically disordered protei

31 D simulations to compare previously proposed calcitonin fibril structures.

32 ar dynamics (MD) methods, finding that human calcitonin forms an alpha-helix.

33 teral parabrachial nucleus (PBel) containing calcitonin gene related peptide (PBel(CGRP) neurons) are

34 arch into the therapeutic potential of alpha-calcitonin gene-related peptide (alpha-CGRP) has been li

35 of exon 5 of Calca, which encodes the alpha-calcitonin gene-related peptide (alpha-CGRP), in intesti

36 s, increased hippocampal expression of alpha calcitonin gene-related peptide (alphaCGRP) transcripts,

37 Intravenous alpha-calcitonin gene-related peptide (alphaCGRP)(8-37) produc

38 Here, we report that calcitonin gene-related peptide (CGRP) activates CFTR-de

39 ing site of the homologous receptors for the calcitonin gene-related peptide (CGRP) and adrenomedulin

40 nables selective recognition of the peptides calcitonin gene-related peptide (CGRP) and adrenomedulli

41 ed receptors involved in energy homeostasis: calcitonin gene-related peptide (CGRP) and amylin recept

42 rleukin (IL)-5, together with Calca-encoding calcitonin gene-related peptide (CGRP) and its cognate r

43 w that ILC2s expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor.

44 s for the treatment of acute migraine target calcitonin gene-related peptide (CGRP) and serotonin (5-

45 irst evidence that antisera directed against calcitonin gene-related peptide (CGRP) and substance P c

46 expression of the potent vasoactive agents' calcitonin gene-related peptide (CGRP) and vascular endo

47 of asymmetric axosomatic synapses containing calcitonin gene-related peptide (CGRP) and vGluT2.

48 ntibody and double stained with chicken anti-calcitonin gene-related peptide (CGRP) antibody.

49 Calcitonin gene-related peptide (CGRP) evokes anxiety-li

50 The calcitonin gene-related peptide (CGRP) family of G prote

51 pain, inhibited release of the neuropeptide calcitonin gene-related peptide (CGRP) from dorsal root

52 CIM0216 elicited the release of the peptides calcitonin gene-related peptide (CGRP) from sensory nerv

53 ovided strong evidence that the neuropeptide calcitonin gene-related peptide (CGRP) has a key role in

54 emale-biased disorder.SIGNIFICANCE STATEMENT Calcitonin gene-related peptide (CGRP) has long been imp

55 usion of neural factors, norepinephrine, and calcitonin gene-related peptide (CGRP) in denervated kid

56 y of evidence supports an important role for calcitonin gene-related peptide (CGRP) in migraine patho

57 The pivotal role of calcitonin gene-related peptide (CGRP) in migraine patho

58 Here, we show that neurons expressing calcitonin gene-related peptide (CGRP) in the parabrachi

59 In contrast with this, infusion of calcitonin gene-related peptide (CGRP) into BNST was rep

60 SIGNIFICANCE STATEMENT: The neuropeptide calcitonin gene-related peptide (CGRP) is a central play

61 Calcitonin gene-related peptide (CGRP) is a classic mole

62 Calcitonin gene-related peptide (CGRP) is a key element

63 The neuropeptide calcitonin gene-related peptide (CGRP) is a key player i

64 Calcitonin gene-related peptide (CGRP) is a neuropeptide

65 Calcitonin gene-related peptide (CGRP) is a potent arter

66 Calcitonin gene-related peptide (CGRP) is a potent neuro

67 Calcitonin gene-related peptide (CGRP) is a potent vasod

68 Calcitonin gene-related peptide (CGRP) is a validated ta

69 The neuropeptide calcitonin gene-related peptide (CGRP) is associated wit

70 Calcitonin gene-related peptide (CGRP) is crucial in the

71 inase and estrogen receptor (CreER) into the calcitonin gene-related peptide (CGRP) locus that encode

72 very migraine patient.SIGNIFICANCE STATEMENT Calcitonin gene-related peptide (CGRP) monoclonal antibo

73 the contribution to cancer anorexia made by calcitonin gene-related peptide (CGRP) neurons in the pa

74 Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor h

75 Calcitonin gene-related peptide (CGRP) pathway inhibitor

76 The calcitonin gene-related peptide (CGRP) pathway is a prom

77 The calcitonin gene-related peptide (CGRP) pathway is import

78 The neuropeptide calcitonin gene-related peptide (CGRP) plays a critical

79 Calcitonin gene-related peptide (CGRP) receptor antagoni

80 Calcitonin gene-related peptide (CGRP) receptor antagoni

81 t is an orally administered, small-molecule, calcitonin gene-related peptide (CGRP) receptor antagoni

82 sign enabled the discovery of 8, HTL22562, a calcitonin gene-related peptide (CGRP) receptor antagoni

83 eover NO increased neuronal excitability and calcitonin gene-related peptide (CGRP) release and these

84 PA1-selective agonist, mustard oil (MO), for calcitonin gene-related peptide (CGRP) release from rat

85 rmacologic inhibition of substance P (SP) or calcitonin gene-related peptide (CGRP) signaling in Vglu

86 pharmacological inhibition of substance P or calcitonin gene-related peptide (CGRP) signaling in Vglu

87 had no effect on acanthosis; restoration of calcitonin gene-related peptide (CGRP) signaling reverse

88 DCN A and C fibers and their relationship to calcitonin gene-related peptide (CGRP) staining in the d

89 Calcitonin gene-related peptide (CGRP) stimulated CLR en

90 s depend, in part, on its ability to release calcitonin gene-related peptide (CGRP) through an uniden

91 els of migraine, we show that application of calcitonin gene-related peptide (CGRP) to the rat dura m

92 sal root ganglia (DRG), some neurons express calcitonin gene-related peptide (CGRP) without substance

93 y trigeminal nerve fibers immunoreactive for calcitonin gene-related peptide (CGRP), a marker for pol

94 that reacted with a labeled antibody against calcitonin gene-related peptide (CGRP), a marker of noci

95 ceptors directly respond to STm by releasing calcitonin gene-related peptide (CGRP), a neuropeptide t

96 Calcitonin gene-related peptide (CGRP), adrenomedullin (

97 tor (CLR) for calcitonin (CT), amylin (Amy), calcitonin gene-related peptide (CGRP), and adrenomedull

98 rves induced production of the neuropeptide, calcitonin gene-related peptide (CGRP), and CGRP treatme

99 ron somata, especially those also expressing calcitonin gene-related peptide (CGRP), and in central p

100 The relative numbers of neurons containing calcitonin gene-related peptide (CGRP), cocaine- and amp

101 ed transcript (cart), cholecystokinin (cck), calcitonin gene-related peptide (cgrp), galanin, hypocre

102 b, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investi

103 reactive (IR) for neurofilament 200 (N52) or calcitonin gene-related peptide (CGRP), or labeled by is

104 characterized by using six neuronal markers: calcitonin gene-related peptide (CGRP), substance P (SP)

105 Calcitonin gene-related peptide (CGRP), the most abundan

106 n exists between migraine and release of the calcitonin gene-related peptide (CGRP), the possibility

107 the PBel neurons that respond to CO2 express calcitonin gene-related peptide (CGRP), we hypothesized

108 ological states, we injected the vasodilator calcitonin gene-related peptide (CGRP), which induces he

109 nerve fibers innervating taste buds contain calcitonin gene-related peptide (CGRP), which may be as

110 We show that a subset of adult calcitonin gene-related peptide (CGRP)-expressing myente

111 In contrast, calcitonin gene-related peptide (CGRP)-expressing neuron

112 Previously, we identified calcitonin gene-related peptide (CGRP)-expressing neuron

113 afferent neurons are almost exclusively non-calcitonin gene-related peptide (CGRP)-immunoreactive (-

114 as to identify the location, morphology, and calcitonin gene-related peptide (CGRP)-immunoreactivity

115 in Old MAs along with impaired dilatation to calcitonin gene-related peptide (CGRP).

116 ophagus were removed, fixed, and stained for calcitonin gene-related peptide (CGRP).

117 of the membrane based on their expression of calcitonin gene-related peptide (CGRP).

118 nduced HSC mobilization via the secretion of calcitonin gene-related peptide (CGRP).

119 ct contact with peripheral neurons secreting calcitonin gene-related peptide (CGRP).

120 , corticotrophin releasing hormone (CRH) and calcitonin gene-related peptide (CGRP).

121 le axons and nerve endings immunoreactive to calcitonin gene-related peptide (CGRP).

122 and a population of cisplatin-activated lPBN calcitonin gene-related peptide (CGRP, a marker for glut

123 Gene expression of the neuropeptides calcitonin gene-related peptide (CGRP-alpha) and substan

124 ochemistry analysis using antibodies against calcitonin gene-related peptide (CGRP; sensory nerve fib

125 Here, we used stimulated immunoreactive Calcitonin Gene-Related Peptide (iCGRP) release as a mea

126 d that pIII glutamatergic neurons expressing calcitonin gene-related peptide alpha (CALCA) are NREM-s

127 Biological agents to treat pain (anti-calcitonin gene-related peptide and anti-nerve growth fa

128 d and thin myelinated afferents labeled with calcitonin gene-related peptide and isolectin B4, and in

129 Many colocalize with calcitonin gene-related peptide and isolectin B4, and th

130 peptidergic nociceptive fibers (positive for calcitonin gene-related peptide and substance P) and mye

131 subset of sensory neurons that colabel with calcitonin gene-related peptide and TRPV1 suggestive of

132 assess the safety and efficacy of monoclonal calcitonin gene-related peptide antibodies for the preve

133 Variants of the calcitonin gene-related peptide artificially activate va

134 ADA reduces blood levels of the neuropeptide calcitonin gene-related peptide but increases the neurop

135 in trigeminal sensory afferents, increasing calcitonin gene-related peptide expression and basal tri

136 een confirmed, and the subsequent release of calcitonin gene-related peptide from a mouse heart has b

137 Calcitonin gene-related peptide immunolabeled (peptiderg

138 ated release of the neuropeptide transmitter calcitonin gene-related peptide in mouse DRG neurons.

139 evention and provide support for the role of calcitonin gene-related peptide in the pathogenesis of m

140 vascular activation, including expression of calcitonin gene-related peptide in the trigeminal gangli

141 The potent vasodilator calcitonin gene-related peptide mediates neurogenic infl

142 E11.5, followed by neurofilament-M neurons, calcitonin gene-related peptide neurons (peak cell cycle

143 ibers were predominant (tyrosine hydroxylase/calcitonin gene-related peptide ratio 25.1 +/- 33.4; p <

144 ric synthesis of the major metabolite of the calcitonin gene-related peptide recepotor antagonist BMS

145 Ubrogepant is an oral, small-molecule calcitonin gene-related peptide receptor antagonist for

146 Treatment of a migraine attack with the oral calcitonin gene-related peptide receptor antagonist rime

147 Rimegepant is a calcitonin gene-related peptide receptor antagonist that

148 t is an orally administered, small-molecule, calcitonin gene-related peptide receptor antagonist that

149 Ubrogepant is an oral calcitonin gene-related peptide receptor antagonist unde

150 Rimegepant, a small molecule calcitonin gene-related peptide receptor antagonist, has

151 : 5-HT1F receptor agonists, and the gepants: calcitonin gene-related peptide receptor antagonists, in

152 Calcitonin gene-related peptide receptor has been implic

153 ore used to migraine, such as naproxen and a calcitonin gene-related peptide receptor inhibitor, olce

154 human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, for the preven

155 ain G-protein-coupled receptors, such as the calcitonin gene-related peptide receptor, to the plasma

156 tch-clamp electrophysiology, Ca(2+) imaging, calcitonin gene-related peptide release assay from tissu

157 icin-evoked nocifensive responses, increased calcitonin gene-related peptide release from hindpaw ski

158 Acute infection activates calcitonin gene-related peptide sensory neurons coupled

159 ch, in return, allowed endoneurally released calcitonin gene-related peptide to pass through the nerv

160 As for sensory axons (immunostained for calcitonin gene-related peptide) in the urinary bladders

161 ng factor, thyrotropin-releasing hormone and calcitonin gene-related peptide) involved in the mediati

162 Because the sensory neuropeptide CGRP (calcitonin gene-related peptide) regulates host response

163 1, TRPA1, and neuropeptides (substance P and calcitonin gene-related peptide) using genetic and pharm

164 alphaCGRP (alpha calcitonin gene-related peptide), one of the strongest v

165 axons (peripherin-positive axons containing calcitonin gene-related peptide), without changes in sym

166 The expression of calcitonin gene-related peptide, a marker for peptidergi

167 omatostatin, gastric inhibitory polypeptide, calcitonin gene-related peptide, and adrenomedullin.

168 apsaicin measured by (Ca(2+))(i), release of calcitonin gene-related peptide, and inward currents.

169 e fly homolog of the vertebrate neuropeptide calcitonin gene-related peptide, as a circadian wake-pro

170 ide, but was induced by aristolochic acid I, calcitonin gene-related peptide, endothelin-1, gentamici

171 42, a fully humanised monoclonal antibody to calcitonin gene-related peptide, for migraine prevention

172 and efficacy of galcanezumab, an antibody to calcitonin gene-related peptide, in patients with migrai

173 anezumab, a humanized monoclonal antibody to calcitonin gene-related peptide, may be a preventive tre

174 nt differences were observed in substance P, calcitonin gene-related peptide, or neuropeptide Y prote

175 Calcitonin gene-related peptide, vesicular acetylcholine

176 modicum of investment, new targets, such as calcitonin gene-related peptide-based mechanisms, and en

177 Here we identify calcitonin gene-related peptide-expressing neurons in th

178 dult mice, MET was restricted to a subset of calcitonin gene-related peptide-immunoreactive (IR) myen

179 Calcitonin gene-related peptide-immunoreactive sensory i

180 y, accompanied by increased axonal growth of calcitonin gene-related peptide-labeled fibers in the do

181 ased the density of PGP9.5-positive, but not calcitonin gene-related peptide-positive, free nerve end

182 sin I, SV2, or syntaxin and the neuropeptide calcitonin gene-related peptide.

183 ion of terminals within the VPMpc containing calcitonin gene-related peptide.

184 geted for anti-tyrosine hydroxylase and anti-calcitonin gene-related peptide.

185 matostatin, nefstatin-1, interleukin-11, and calcitonin gene-related peptide.

186 lar motoneurons, are also immunoreactive for calcitonin gene-related peptide.

187 n was driven by the nociceptive neuropeptide calcitonin gene-related peptide.

188 staltic transmitters 5-hydroxytryptamine and calcitonin gene-related peptide; antagonists of these tr

189 fibers containing the sensory neuropeptides, calcitonin gene-related polypeptide, and substance P, oc

190 mpanied by substantial increases of neuronal calcitonin gene-related polypeptide-alpha (CGRP) in both

191 l circuit for appetite suppression involving calcitonin gene-related protein (CGRP)-expressing PBN (C

192 hydroxylase (sympathetic neuron marker; TH), calcitonin gene-related protein (peptidergic nociceptor

193 Benefits of calcitonin-gene related peptide (CGRP) inhibition have n

194 The neuroactive peptide calcitonin-gene related peptide (CGRP) is known to act a

195 the lateral parabrachial nucleus (lPBN) and calcitonin-gene related peptide (CGRP) projections from

196 des vasoactive intestinal polypeptide (VIP), calcitonin-gene related peptide (CGRP), substance P (SP)

197 ensory axons expressing Phox2b, substance P, calcitonin-gene related peptide, and the serotonin recep

198 knowledge, between the internal dynamics of calcitonin-gene-related peptide (CGRP) and amylin (islet

199 express both IL-33 and the receptor for the calcitonin-gene-related peptide (CGRP); and demonstrate

200 Deletion or silencing of calcitonin-gene-related peptide alpha (alphaCGRP) gene e

201 and cOv are characterized with expression of calcitonin-gene-related peptide and cholecystokinin.

202 ry afferent terminal markers isolectin B4 or calcitonin-gene-related peptide immunoreactivity.

203 vation by icilin blocked capsaicin-triggered calcitonin-gene-related peptide release from colon tissu

204 onic levels of the inflammatory neuropeptide calcitonin-gene-related peptide, although inflammatory i

205 f rat spinal sensory afferents identified by Calcitonin-Gene-Related-Peptide (CGRP) for peptidergic t

206 sh-fixed and stained for immunoreactivity to calcitonin-gene-related-peptide (CGRP).

207 etrogradely labeled neurons from the DP were calcitonin-gene-related-peptide-positive (peptide-expres

208 nces in outcomes were noted for alendronate, calcitonin, glipizide, or quinapril.

209 While calcitonin has been used in therapy for osteoporosis and

210 rosis and Paget's disease for decades, human calcitonin (hCT) forms fibrils in aqueous solution that

211 nteractions leading to fibrillation of human calcitonin (hCT), a peptide hormone important in calcium

212 0 in its extracellular domain (ECD) enhances calcitonin hormone affinity with the proximal GlcNAc res

213 o degradative release of encapsulated salmon calcitonin in gastric conditions while yielding rapid an

214 igin of thyroid C cells, the major source of calcitonin in mammals and ancestors to neuroendocrine th

215 Calcitonin is a 32-amino acid thyroid hormone that can f

216 Calcitonin is a 32-residue peptide hormone known for its

217 Calcitonin is a peptide hormone consisting of 32 amino a

218 The peptide hormone calcitonin is intimately connected with human cancer dev

219 he molecular mechanism of fiber formation by calcitonin is not well understood.

220 e relationship between the incremental serum calcitonin level before reoperation and the number of ly

221 This shows that the cellular calcitonin level is maintained to mitigate effects of bi

222 artment, and for an MTC with increased basal calcitonin level of 20-200 pg/ml (ipsilateral dissection

223 led to long-term remission (ie, undetectable calcitonin level) in 15 (83%) of 18 individuals (2 patie

224 means of 5.3 vs 17.6 years) and having lower calcitonin levels (means of 115 vs 25,519 pg/mL), smalle

225 ary thyroid cancer (MTC) stratified by basal calcitonin levels before reoperation and the number of l

226 When serum calcitonin levels exceeded 1000 pg/mL before reoperation

227 ective CND based on preoperative basal serum calcitonin levels is an effective and safe alternative t

228 olvement, and in MTC with preoperative basal calcitonin levels more than 200 pg/ml (normal limit <10

229 With serum calcitonin levels of 1000 pg/mL or lower before reoperat

230 When serum calcitonin levels were 1000 pg/mL or lower before reoper

231 Immediate postoperative serum calcitonin levels were in the normal range (<5 pg/mL) in

232 by knowledge of specific exon mutations and calcitonin levels.

233 d based on specific exon mutations and serum calcitonin levels.

234 Their actions are mediated by the class B calcitonin-like G protein-coupled receptor (CLR), which

235 ate crosslinker, a small polypeptide (salmon calcitonin) loads and releases up to 45 mug/mg hydrogel

236 impact on DT (>/=100% increase of pre-pRAIT calcitonin or CEA DT or prolonged decrease of the biomar

237 nitiation of treatment with bisphosphonates, calcitonin, or raloxifene were treated as competing risk

238 two intrinsically disordered proteins of the calcitonin peptide family.

239 nd disordered aggregation in peptides of the calcitonin peptide family.

240 n, whereas atrial-specific overexpression of calcitonin prevents both atrial fibrosis and fibrillatio

241 Medullary thyroid cancer arises from calcitonin-producing C-cells and accounts for 3-5% of al

242 y in the atria, atrial-specific knockdown of calcitonin promotes atrial fibrosis and increases and pr

243 asts reveals little change after exposure to calcitonin, proteomic analysis shows extensive alteratio

244 non-vertebral fracture (for alendronate and calcitonin), psychiatric hospitalization rate (for sertr

245 ession and that amylin functions through the calcitonin receptor (CalcR) and receptor activity modify

246 f DEX with D3 or PTH increased gene encoding calcitonin receptor (Calcr), acid phosphatase 5, tartrat

247 selectivity of the class B G protein-coupled calcitonin receptor (CTR) and the CTR-like receptor (CLR

248 he class B G protein-coupled receptor (GPCR) calcitonin receptor (CTR) is a drug target for osteoporo

249 how that the core component of the AmyR, the calcitonin receptor (CTR), is expressed on VTA dopamine

250 , the core component of the amylin receptor, calcitonin receptor (CTR), was depleted from POMC neuron

251 The crystal structure of the human calcitonin receptor ectodomain (CTR ECD) in complex with

252 or activity-modifying protein-1 (RAMP-1) and calcitonin receptor gene (CT-R) expression in striatum [

253 consisting of 32 amino acid residues and the calcitonin receptor is a Class B G protein-coupled recep

254 Global disruption of calcitonin receptor signalling in mice causes atrial fib

255 In addition, Calcr (calcitonin receptor), which regulates osteoclast surviva

256 cture of a full-length class B receptor, the calcitonin receptor, in complex with peptide ligand and

257 Expression of RANK, TRAP, cathepsin K, calcitonin receptor, matrix metalloproteinase 9, NFATc1,

258 enomedullin (AM) and its receptor complexes, calcitonin receptor-like receptor (Calcrl) and receptor

259 activity modifying protein 1 (RAMP1) and the calcitonin receptor-like receptor (CALCRL) to promote eg

260 Rs) is formed through the association of the calcitonin receptor-like receptor (CLR) and one of three

261 pression and define cellular localization of calcitonin receptor-like receptor (CLR) and receptor act

262 resence of CGRP and its receptor components, calcitonin receptor-like receptor (CLR) and receptor act

263 Calcitonin receptor-like receptor (CLR) and the receptor

264 AM and its putative receptor calcitonin receptor-like receptor (CLR) are implicated i

265 ) with the G protein-coupled receptor (GPCR) calcitonin receptor-like receptor (CLR) enables selectiv

266 e contribution of endosomal signaling of the calcitonin receptor-like receptor (CLR) to pain transmis

267 ization of a G protein-coupled receptor, the calcitonin receptor-like receptor (CLR), and receptor ac

268 ide mediates neurogenic inflammation via the calcitonin receptor-like receptor (CLR).

269 Adrenomedullin (AM) signals through calcitonin receptor-like receptor and receptor activity-

270 Knockdown of ADM, calcitonin receptor-like receptor, and receptor activity

271 duce arterial differentiation in ECs via the calcitonin receptor-like receptor, thus revealing a surp

272 duals with normal heart rhythm, with loss of calcitonin receptors in the fibroblast membrane.

273 Amylin is a calcitonin-related peptide co-secreted with insulin, whi

274 ndary visceral nucleus, which also expressed calcitonin-related polypeptide alpha (calca), a marker o

275 II afferents of two genes found in C-fibers: calcitonin-related polypeptide alpha (Calca/Cgrpalpha),

276 rs for fast motor neurons (Chondrolectin and calcitonin-related polypeptide alpha [Calca]), we analyz

277 that substantially change the proportions of calcitonin-related species released into the culture med

278 hermore, the amylin and GLP-1 analogs salmon calcitonin (sCT) and liraglutide produce synergistic-lik

279 insertion into the disulfide bond of salmon calcitonin (sCT) demonstrates the utility for fluorescen

280 vitro, and absorption enhancement of salmon calcitonin (sCT) in vivo.

281 Salmon calcitonin (sCT) is a drug which has been shown to have

282 onjugation to the therapeutic peptide salmon calcitonin (sCT) via bridging of the Cys(1)-Cys(7) disul

283 sidues of both leucine enkephalin and salmon calcitonin (sCT) were targeted using appropriate diazoni

284 Reaction of salmon calcitonin (sCT) with 2,3-dibromomaleimide (1.1 excess)

285 ion of acylation of octreotide (Oct), salmon calcitonin (sCT), and human parathyroid hormone (hPTH) w

286 All three proteins bound salmon calcitonin (sCT).

287 interactions with the peptide hormone salmon calcitonin (sCT).

288 strate their capabilities in vivo for salmon calcitonin (sCT).

289 a neuroendocrine cancer that originates from calcitonin-secreting parafollicular cells, or C cells.

290 for immuno-PET in relapsed MTC patients with calcitonin serum levels greater than 150 pg/mL.

291 a broad localization within the brain, while calcitonin, SIFamide, vasotocin, RGWamide, DLamide, FLam

292 a significant physiological impact of amylin/calcitonin signaling in CTR-POMC neurons on energy metab

293 Strategies to restore disrupted myocardial calcitonin signalling thus may offer therapeutic avenues

294 ork, we first predict the structure of human calcitonin through two complementary molecular dynamics

295 e tested in vitro with model proteins salmon calcitonin, urokinase, and rituximab to determine the ef

296 int disruption afforded by dexamethasone and calcitonin was established in comparison to the melanoco

297 l neck dissection was done only if the serum calcitonin was greater than 40 pg/mL.

298 ype II turn is the preferred conformation of calcitonin, whereas a type I turn is the preferred confo

299 al performance for the small peptide, salmon calcitonin, whereas lower crosslinking density of 1 mol%

300 ly investigated with a small protein, salmon calcitonin, which could be analyzed both without and wit